Despite the complex nature of TGF-β-mediated regulatory signaling in the tumor microenvironment, many aspects of signaling through this pathway have been targeted for therapeutic intervention with the use of systemic and cell-specific strategies that have demonstrated some degree of efficacy [31]. This evidence concerns the gene TGFB1 and neoplasm.